- Home
- CPRX vs BL Comparison
CPRX vs BL Comparison
Compare CPRX & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | BL |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 2006 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CPRX | BL |
|---|---|---|
| Price | $23.64 | $35.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 13 |
| Target Price | $32.50 | ★ $57.23 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 1.68 | 0.39 |
| Revenue | $119,072,803.00 | ★ $177,031,000.00 |
| Revenue This Year | $7.14 | $12.62 |
| Revenue Next Year | $7.68 | $10.76 |
| P/E Ratio | ★ $13.68 | $89.92 |
| Revenue Growth | 16.39 | ★ 43.78 |
| 52 Week Low | $19.05 | $31.75 |
| 52 Week High | $26.56 | $59.57 |
Technical Indicators
Market Signals| Indicator | CPRX | BL |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 33.84 |
| Support Level | $22.25 | N/A |
| Resistance Level | $24.81 | $58.86 |
| Average True Range (ATR) | 0.97 | 2.05 |
| MACD | -0.11 | 0.13 |
| Stochastic Oscillator | 52.61 | 32.00 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.